Azadeh Golipour - Feb 1, 2024 Form 4 Insider Report for AVROBIO, Inc. (AVRO)

Role
Chief Technology Officer
Signature
/s/ Steven Avruch, Attorney in Fact for Azadeh Golipour
Stock symbol
AVRO
Transactions as of
Feb 1, 2024
Transactions value $
-$14,698
Form type
4
Date filed
2/5/2024, 08:01 PM
Previous filing
Jun 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVRO Common Stock Options Exercise $0 +37.3K +121.33% $0.00 68.1K Feb 1, 2024 Direct
transaction AVRO Common Stock Tax liability -$14.7K -12.2K -17.96% $1.20 55.9K Feb 5, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVRO Restricted Stock Unit Options Exercise $0 -37.3K -25% $0.00 112K Feb 1, 2024 Common Stock 37.3K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 10, 2021, the filer was granted 36,344 RSUs. 50% of the shares vested on the second anniversary of the grant date and the remaining 50% vest on the third anniversary of the grant date. This balance includes 18,172 unvested shares.
F2 The shares subject to the RSU shall vest over 4 years, with 25% vesting annually on each anniversary of the Vesting Commencement Date of February 1, 2023.